BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31115855)

  • 21. Diagnostic clues indicating tall cell variants of papillary thyroid carcinoma in fine needle aspiration.
    Tanaka A; Hirokawa M; Higuchi M; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Diagn Cytopathol; 2019 May; 47(5):452-457. PubMed ID: 30582297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appropriateness of the revised Japanese guidelines' risk classification for the prognosis of papillary thyroid carcinoma: a retrospective analysis of 5,845 papillary thyroid carcinoma patients.
    Ito Y; Miyauchi A; Oda H; Masuoka H; Higashiyama T; Kihara M; Miya A
    Endocr J; 2019 Feb; 66(2):127-134. PubMed ID: 30626761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
    Ryu YJ; Cho JS; Park MH; Yoon JH
    BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implications of papillary thyroid carcinoma with tall-cell features.
    Ganly I; Ibrahimpasic T; Rivera M; Nixon I; Palmer F; Patel SG; Tuttle RM; Shah JP; Ghossein R
    Thyroid; 2014 Apr; 24(4):662-70. PubMed ID: 24262069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Level V Metastasis, a Novel Predicative Factor for Recurrence in N1b Papillary Thyroid Carcinoma.
    Wu Y; Li J; Wu X; Dai L
    Curr Pharm Des; 2018; 24(5):559-563. PubMed ID: 28990528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
    Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological features of recurrent papillary thyroid cancer.
    Zhu J; Wang X; Zhang X; Li P; Hou H
    Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
    Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
    J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.
    Liu Z; Zeng W; Chen T; Guo Y; Zhang C; Liu C; Huang T
    Oncotarget; 2017 Jan; 8(4):6222-6232. PubMed ID: 28009980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.
    Lee HS; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    World J Surg; 2015 Aug; 39(8):1943-50. PubMed ID: 25820911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
    Nardone HC; Ziober AF; LiVolsi VA; Mandel SJ; Baloch ZW; Weber RS; Mick R; Ziober BL
    Cancer; 2003 Oct; 98(7):1386-93. PubMed ID: 14508824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytological diagnosis of papillary thyroid carcinoma with tall cells on ThinPrep liquid-based cytology.
    Baum JE; Soong L; Scognamiglio T; Margolskee EM; Hoda RS; Rao R
    Diagn Cytopathol; 2019 Jun; 47(6):541-546. PubMed ID: 30648353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Preoperative US Features and Recurrence in Patients with Classic Papillary Thyroid Carcinoma.
    Kim SY; Kwak JY; Kim EK; Yoon JH; Moon HJ
    Radiology; 2015 Nov; 277(2):574-83. PubMed ID: 25955580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
    Feng J; Shen F; Cai W; Gan X; Deng X; Xu B
    Endocrine; 2018 Sep; 61(3):499-505. PubMed ID: 29909599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prognosis of Papillary Thyroid Cancer with Initial Distant Metastasis is Strongly Associated with Extensive Extrathyroidal Extension: A Retrospective Cohort Study.
    Lee YK; Kim D; Shin DY; Lee CR; Lee EJ; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Park CS
    Ann Surg Oncol; 2019 Jul; 26(7):2200-2209. PubMed ID: 30895495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
    Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
    Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
    Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME
    JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of Forkhead box Q1 correlates with poor prognosis in papillary thyroid carcinoma.
    Li Y; Wang HQ; Wang AC; Li YX; Ding SS; An XJ; Shi HY
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):334-342. PubMed ID: 30378716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.
    Ito Y; Hirokawa M; Miyauchi A; Higashiyama T; Kihara M; Miya A
    World J Surg; 2017 Mar; 41(3):742-747. PubMed ID: 27807709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.